Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2005
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267161 Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050266520 Process for the synthesis of peptides
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005DE102004023606A1 Verfahren zur Herstellung von N,N'-Carbonyldiazolen A process for the preparation of N, N'-carbonyldiazoles
12/01/2005DE102004022970A1 Neue Imidazolderivate, deren Herstellung und deren Verwendung als Intermediate zur Herstellung von Arzneimitteln und Pestiziden New Imidazole derivatives, their preparation and their use as intermediates for the preparation of medicaments and pesticides,
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
11/2005
11/30/2005EP1600444A1 Process for the preparation of N,N'-Carbonyldiazoles
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP1064268B1 Novel cationic compounds, their use as coupling agents for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods
11/30/2005EP0960121B1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1702067A Method of preparing N,N'-carbonyl diazole
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229102C Novel couplers for use in oxidative hair dyeing
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969710 Compounds
11/29/2005US6969697 Substituted benzoylcyclohexenones
11/24/2005WO2005110999A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/24/2005WO2005110998A1 Scalable synthesis of imidazole derivatives
11/24/2005WO2005110997A1 Bisguanidine-compound optical resolver and separating agent for chiral molecule
11/24/2005WO2005110996A1 Novel cis-imidazolines
11/24/2005WO2005110980A2 Aryl sulfones and uses related thereto
11/24/2005WO2004089313A3 Novel olanzapine forms and related methods of treatment
11/24/2005US20050261505 Process for recovering 1,3-dimethyl-2-imidazolidinone
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261352 Such as methyl 2-bromo-5-formyl-3-(3-methyl-2-buten-1-yl)-3H-imidazole-4-carboxylate
11/24/2005US20050261309 Imidazole compounds
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005DE4340725B4 UV-Absorber UV absorber
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2566660A1 Bisguanidine compound optical resolver and chiral molecule separating agent
11/24/2005CA2565189A1 Cis-2,4,5-triphenyl imidazolines and their use as anti-cancer medicaments
11/24/2005CA2562857A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/23/2005EP1598342A1 A process for recovering 1,3-dimethyl-2-imidazolidinone
11/23/2005EP1597244A1 Ethynyl derivatives serving as factor xa inhibitors
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/23/2005CN1228330C Imidazole derivatives or their salts
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228325C Biguanide derivatives
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005109562A1 Material for electrolytic solution, ionic material-containing composition and use thereof
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108374A1 Insecticidal diazole and triazole derivatives
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2004082602A3 Carboxamide spirohydantoin cgrp receptor antagonists
11/17/2005US20050256334 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof
11/17/2005US20050256176 Sulphonamide derivatives and their use as tace inhibitors
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256161 Melanin concentrating hormone receptor antagonists
11/17/2005US20050256121 Substituted 2,5-heterocyclic derivatives
11/17/2005US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation
11/17/2005US20050256113 Anti-cytokine heterocyclic compounds
11/17/2005US20050255171 synergistic; one imidazole compound and at least one fungicide for Phycomycetes and an inorganic copper fungicide as an active ingredient; curative and/or preventive effects on plant diseases
11/17/2005CA2565854A1 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1324975B1 Dynamic resolution of isomers and resolved isomers
11/16/2005CN1697650A Non-nucleoside reverse transcriptase inhibitors
11/16/2005CN1696117A Method for preparing ion liquid in halogenated alkyl imidazole type
11/16/2005CN1695451A Fungicidal active compound mixture
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists
11/15/2005US6965036 Intermediates for guanidine mimics as factor Xa inhibitors
11/15/2005US6965035 Mixture of 1,3-dihalo-5,5-dimethylhydantoin in binder
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964959 Use of a methylol-containing compound to treat tumors
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005105783A1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105766A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
11/10/2005WO2005105756A1 Ionic liquid and process for producing the same
11/10/2005WO2005105752A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105729A1 Polyamine analogs that activate antizyme frameshifting
11/10/2005WO2005105079A2 Novel imidazoles
11/10/2005US20050250957 Compounds containing thiosulfate moieties
11/10/2005US20050250948 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 345